Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Clasificación en acciones #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Precio por acción
$2.17
Capitalización bursátil
$249.58M
Cambio (1 día)
-1.67%
Cambio (1 año)
96.34%
País
CA
Comercio Cardiol Therapeutics Inc. (CRDL)

Categoría

Historial del precio de la acción de Cardiol Therapeutics Inc. (CRDL)
Precio más alto de cierre: $2.19 el 2026-09-01

Precio más bajo de cierre: $3.27 el 2018-12-01
Historial del precio de la acción de Cardiol Therapeutics Inc. desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 17.16%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.46 25.80%
CH